Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Frasers Group stops FRC from publishing key findings of review - report

(Sharecast News) - Mike Ashley's Frasers Group has reportedly refused to allow the Financial Reporting Council to publish the key findings of a review into the retail group's latest annual report. According to The Times, Frasers has withheld consent for the regulator to issue a case summary after entering into "substantive inquiries" with the company.

It is the second year running when the Financial Reporting Council (FRC) has conducted a review of Frasers' annual report and when Frasers has refused to allow the issue to be made public, The Times has learnt.

There are only 14 cases, or 4% of the total - three of which concern Frasers or a group company - in which companies have withheld consent since the regulator introduced a more transparent corporate reporting review regime after the independent Sir John Kingman review in 2018.

The regime was introduced when Sir Jon Thompson was chief executive of the regulator. Thompson, 59, a former chief executive of HM Revenue & Customs, is due to join Frasers' board this year as a non-executive director.

It means Frasers is the only FTSE 100 company to have withheld consent.

The issues raised by the FRC as part of its reviews are unknown but are understood not to relate to audit issues.

A spokeswoman for Frasers told The Times: "The business has already addressed any queries raised by the FRC to their satisfaction.

"It is perfectly common for the FRC to ask questions in relation to accounts ... It is not apparent to the business that there is any benefit in publishing outcomes to such questioning where matters have already been resolved and so this has been its approach."

Share this article

Related Sharecast Articles

UBS to book $900m provision over Greensill supply financing funds
(Sharecast News) - Swiss banking giant UBS announced on Monday that it expected to book a provision of about $900m related to Credit Suisse's funds, tied to the collapsed supply chain financing firm Greensill Capital.
Citi downgrades European equities to 'neutral'
(Sharecast News) - Citi downgraded its stance on European equities on Monday to 'neutral' from 'overweight' as it said near-term risks have increased, with markets narrowing and political uncertainty taking centre stage.
Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.
Somero trading in line with expectations
(Sharecast News) - Somero Enterprises said in an update on Monday that trading for the first five months of 2024 was consistent with expectations.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.